MeiraGTx Holdings plc (MGTX) États Financiers et Données Historiques

MeiraGTx Holdings plc (MGTX) — Prix $12.76 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de MeiraGTx Holdings plc (MGTX): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

MeiraGTx Holdings plc a enregistré un chiffre d'affaires de $81.4M sur le dernier exercice, avec un CAGR sur 5 ans de 39.2%.

Marges des 12 derniers mois: marge brute 97.2%, marge opérationnelle 46.3%, marge nette 19.9%.

Au prix actuel de $12.76, MGTX se négocie à un PER de 15.53 et un ROE de 284.38%. La capitalisation boursière s'établit à $1.2B.

Compte de Résultat (10 ans)

Année2016201720182019202020212022202320242025
Revenus000$13.3M$15.6M$37.7M$15.9M$14.0M$33.3M$81.4M
Coût des Ventes$243081$679177$2.1M00000$23.8M$4.8M
Marge Brute-$243081-$679177-$2.1M$13.3M$15.6M$37.7M$15.9M$14.0M$9.5M$76.5M
R&D$14.0M$22.4M$33.6M$24.9M$33.9M$66.7M$85.7M$103.8M$119.5M$129.6M
Frais Généraux$6.0M$9.3M$44.5M$46.7M$44.2M$43.8M$46.5M$47.3M$54.2M$52.9M
Charges Opérationnelles$20.1M$31.7M$78.1M$71.6M$78.1M$110.5M$132.3M$151.1M$173.7M$182.5M
Résultat Opérationnel-$20.1M-$31.7M-$78.1M-$58.3M-$62.6M-$72.8M-$116.4M-$137.1M-$164.2M-$106.0M
EBITDA-$19.8M-$31.0M-$78.1M-$52.5M-$53.7M-$71.4M-$116.1M-$57.1M-$121.7M-$89.4M
Charges d'Intérêt$25440$42863$33429$48612$139203$288000$4.9M$13.2M$13.3M$12.2M
Résultat Avant Impôts-$19.8M-$31.0M-$83.3M-$54.7M-$58.0M-$79.6M-$129.6M-$84.0M-$147.8M-$114.2M
Impôts00-$4743910000000
Résultat Net-$19.5M-$31.0M-$82.9M-$54.7M-$58.0M-$79.6M-$129.6M-$84.0M-$147.8M-$114.2M
BPA$-1.01$-3.62$-4.37$-1.58$-1.43$-1.80$-2.87$-1.49$-2.12$-1.42
BPA Dilué$-1.01$-3.62$-4.37$-1.58$-1.43$-1.80$-2.87$-1.49$-2.12$-1.42
Actions en Circulation (Diluées)$19.2M$8.6M$18.9M$33.2M$37.7M$44.1M$45.2M$56.5M$69.8M$80.4M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$410000$75.4M$293000$321.4M
Marge Brute$97000$74.9M-$2.9M$314.3M
Résultat Opérationnel-$46.1M$26.5M-$40.8M$244.4M
EBITDA-$44.0M$21.3M-$40.5M$323.0M
Résultat Net-$50.5M$15.1M-$46.3M$160.7M
BPA$-0.62$0.19$-0.57$1.76
BPA Dilué$-0.62$0.19$-0.57$1.71

Bilan (10 ans)

Année2016201720182019202020212022202320242025
Trésorerie$17.5M$8.5M$68.1M$227.2M$209.5M$137.7M$115.5M$129.6M$103.7M$65.9M
Placements à Court Terme0000000000
Créances000$37.1M$55.4M$35.0M$29.0M$23.4M$10.6M$18.3M
Stocks00000000$3850000
Actifs Courants$19.1M$11.5M$74.7M$269.0M$272.6M$183.2M$154.3M$159.6M$123.5M$91.8M
Immobilisations Corporelles$3.0M$14.3M$22.0M$52.9M$87.1M$126.3M$154.1M$156.2M$135.7M$141.9M
Goodwill0000000000
Actifs Incorporels000$777655$3.0M$2.6M$2.1M$1.1M$821000$578000
Actifs Totaux$22.6M$25.9M$96.9M$323.9M$363.7M$320.2M$318.2M$326.7M$269.8M$244.4M
Dettes Fournisseurs$1.5M$7.1M$3.0M$3.8M$7.1M$15.3M$16.6M$16.0M$23.6M$10.1M
Dette à Court Terme0$1.4M0$1.7M$2.6M0000$24.6M
Passifs Courants$6.0M$21.4M$15.5M$49.2M$54.1M$68.1M$82.1M$67.1M$60.8M$122.6M
Dette à Long Terme000000$71.0M$72.1M$73.2M$49.7M
Passifs Totaux$39.7M$73.2M$15.8M$133.1M$125.1M$134.8M$200.5M$188.6M$201.9M$250.2M
Réserves-$34.4M-$65.4M-$148.3M-$203.0M-$261.0M-$340.6M-$470.2M-$554.2M-$702.0M-$816.2M
Capitaux Propres-$17.1M-$47.4M$81.1M$190.8M$238.6M$185.4M$117.7M$138.2M$67.8M-$5.8M
Dette Totale$11473$1.5M$34296$23.2M$22.2M$23.7M$92.2M$89.3M$84.8M$88.7M
Dette Nette-$17.5M-$7.0M-$68.0M-$204.1M-$187.3M-$114.0M-$23.3M-$40.3M-$18.9M$22.8M
Fonds de Roulement$13.0M-$9.9M$59.2M$219.8M$218.4M$115.1M$72.3M$92.5M$62.7M-$30.8M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$14.8M$65.9M$71.5M$143.2M
Actifs Totaux$189.5M$244.4M$244.7M$396.4M
Passifs Totaux$230.0M$250.2M$302.8M$180.7M
Capitaux Propres-$40.6M-$5.8M-$58.1M$215.6M
Dette Totale$88.1M$88.7M$87.5M$112.3M

Tableau de Flux (10 ans)

Année2016201720182019202020212022202320242025
Résultat Net-$19.8M-$31.0M-$82.9M-$54.7M-$58.0M-$79.6M-$129.6M-$84.0M-$147.8M-$114.2M
Amortissements$243081$679177$2.1M$2.2M$4.2M$7.9M$8.6M$13.7M$12.7M$12.7M
Stock-based Compensation$2.8M$3.0M$17.9M$15.9M$18.4M$20.8M$28.6M$27.7M$25.2M$22.1M
Variation du BFR$1.6M$8.5M-$3.9M$56.7M-$32.6M$31.3M$9.6M-$983000$29.6M$28.0M
Cash Flow Opérationnel-$14.4M-$18.1M-$58.9M$20.0M-$64.0M-$10.5M-$73.1M-$105.4M-$104.5M-$46.4M
CapEx-$2.6M-$10.5M-$11.3M-$9.0M-$37.0M-$55.2M-$45.0M-$20.2M-$5.0M-$3.8M
Acquisitions000-$3896560-$6.5M0000
Rachat d'Actions0000000000
Dividendes Payés0000000000
Free Cash Flow-$17.0M-$28.6M-$70.1M$11.1M-$101.0M-$65.7M-$118.1M-$125.5M-$109.5M-$50.2M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$12.2M$46.6M$17.8M-$38.5M
CapEx-$610000-$6.8M-$2.0M$2.0M
Free Cash Flow-$12.8M$39.9M$15.8M-$36.5M
Dividendes Payés0000
Stock-based Compensation$6.0M$32.7M$3.7M-$3.7M

Croissance et Marges (10 ans)

Année2016201720182019202020212022202320242025
Croissance Revenus (annuelle)+17.1%+142.2%-57.8%-12.0%+137.4%+144.6%
Croissance Résultat Net (annuelle)-59.3%-166.9%+33.9%-5.9%-37.2%-62.9%+35.2%-75.9%+22.7%
Croissance BPA (annuelle)-258.4%-20.7%+63.8%+9.5%-25.9%-59.4%+48.1%-42.3%+33.0%
Variation Actions (annuelle)-55.4%+121.0%+75.0%+13.8%+17.0%+2.4%+25.0%+23.6%+15.2%
Croissance FCF (annuelle)-68.6%-145.3%+115.8%-1012.7%+34.9%-79.6%-6.3%+12.8%+54.1%
Marge Brute100.0%100.0%100.0%100.0%100.0%28.5%94.0%
Marge Opérationnelle-438.4%-401.9%-193.0%-730.9%-977.8%-493.4%-130.2%
Marge EBITDA-394.7%-344.9%-189.4%-729.1%-407.0%-365.7%-109.8%
Marge Nette-411.9%-372.6%-211.0%-814.2%-599.5%-444.1%-140.3%
Marge FCF83.2%-648.9%-174.4%-741.6%-895.6%-328.9%-61.7%
Taux d'Imposition Effectif-0.0%-0.0%0.6%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Données par Action (10 ans)

Année2016201720182019202020212022202320242025
FCF par Action$-0.88$-3.34$-3.70$0.33$-2.68$-1.49$-2.61$-2.22$-1.57$-0.62
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$19.2M$8.6M$18.9M$33.2M$37.7M$44.1M$45.2M$56.5M$69.8M$80.4M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Rentabilité des capitaux propres284.38%
Rentabilité du capital investi52.45%
Rentabilité des actifs19.92%
Marge brute97.19%
Marge opérationnelle46.30%
Marge nette19.87%

Santé financière

Dette / Capitaux propres0.52
Ratio de liquidité3.76

Ratios Clés (10 ans)

Année2016201720182019202020212022202320242025
PER-14.85-4.14-2.21-12.67-10.59-13.19-2.27-4.71-2.87-5.60
P/B-16.84-2.712.253.482.395.652.502.876.27-110.38
P/V0.000.000.0049.9536.7027.7918.5028.2912.787.86
Marge Brute0.0%0.0%0.0%100.0%100.0%100.0%100.0%100.0%28.5%94.0%
Marge Opérationnelle0.0%0.0%0.0%-438.4%-401.9%-193.0%-730.9%-977.8%-493.4%-130.2%
Marge Nette0.0%0.0%0.0%-411.9%-372.6%-211.0%-814.2%-599.5%-444.1%-140.3%

Entreprises liées: ABSI · ARVN · ATXS · AVBP · DNA · ERAS · IOVA

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de MGTX: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions